Endothelin-1 and Endothelin Converting Enzyme-1 in Human Atherosclerosis - Novel Targets for Pharmacotherapy in Atherosclerosis

By  

Current Vascular Pharmacology, Vol. 2, Iss. 3, 2004-07 ,pp. : 249-258

Bentham Science Publishers

Access to resources Recommend Favorite

Marinesco-Sjögren Syndrome in an Emirati Child with a Novel Mutation in SIL1 Affecting the 5′ Untranslated Region

By  

Medical Principles and Practice, Vol. 25, Iss. 6, 2016-08 ,pp. : 580-582

Karger

Access to resources Recommend Favorite

Stimulated Release of Endothelin-converting Enzyme is Simultaneous with Tissue-type Plasminogen Activator and Decrease in Coronary Heart Disease

By Sinisalo Juha   Fyhrquist Frej   Syrjälä Martti   Nieminen Markku S.  

Scandinavian Cardiovascular Journal, Vol. 36, Iss. 2, 2002-04 ,pp. : 100-104

Informa Healthcare

Access to resources Recommend Favorite

Protective Role of an Endothelin-Converting Enzyme Inhibitor (FR901533) in Hepatic Ischemia/Reperfusion Injury

By Uhlmann D.   Witzigmann H.   Senninger N.   Hauss J.   Spiegel H-U.  

Microvascular Research, Vol. 62, Iss. 1, 2001-07 ,pp. : 43-54

Academic Press

Access to resources Recommend Favorite

Endothelin-1 and the Aortic Valve

By  

Current Vascular Pharmacology, Vol. 3, Iss. 4, 2005-10 ,pp. : 353-357

Bentham Science Publishers

Access to resources Recommend Favorite